Director Christopher Lynch Sells Shares of Tenet Healthcare Corp
Christopher Lynch, a director at Tenet Healthcare Corp (NYSE:THC), sold 7,978 shares of the company on February 15, 2024, according to a recent SEC Filing. Tenet Healthcare Corp is a diversified healthcare services company that operates hospitals, ambulatory surgery centers, urgent care centers, and imaging centers.
Over the past year, the insider has sold a total of 7,978 shares and has not made any purchases of the company's stock.
The insider transaction history for Tenet Healthcare Corp indicates a trend of insider sales, with 0 insider buys and 8 insider sells over the past year.
On the date of the insider's recent sale, shares of Tenet Healthcare Corp were trading at $89.6, giving the company a market capitalization of $9.234 billion.
The stock's price-earnings ratio stands at 15.92, which is below the industry median of 27.04 and also below the company's historical median price-earnings ratio.
With the current share price of $89.6 and a GuruFocus Value of $76.10, Tenet Healthcare Corp has a price-to-GF-Value ratio of 1.18, indicating that the stock is considered Modestly Overvalued according to the GF Value metric.
The GF Value is calculated based on historical trading multiples, a GuruFocus adjustment factor, and future business performance estimates provided by Morningstar analysts.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
This article first appeared on GuruFocus.
